Cargando…
Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination
The antibody titer of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was observed in 289 healthy healthcare workers who had completed the second dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. Antibody tests were performed using both the automated electroch...
Autores principales: | Kim, Namhee, Minn, Dohsik, Park, Seungman, Roh, Eun Youn, Yoon, Jong Hyun, Park, Hyunwoong, Shin, Sue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167405/ https://www.ncbi.nlm.nih.gov/pubmed/34060264 http://dx.doi.org/10.3346/jkms.2021.36.e158 |
Ejemplares similares
-
Pfizer-BioNTech COVID-19 vaccine safe in older Koreans
Publicado: (2021) -
Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers
por: Im, Jae Hyoung, et al.
Publicado: (2021) -
Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers
por: Kwon, Seok Ryun, et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)